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TAURINE IS ESSENTIAL FOR THE hepatic synthesis of bile salts, such as taurocholate and taurochenodeoxycholate, which are required for the intestinal absorption of fats and lipid-soluble vitamins (5) . To date, hepatocyte heterogeneity has been proposed with regard to the biosynthesis of bile salts: taurine conjugation with bile acids and taurine biosynthesis from cysteine preferentially occurs in the periportal lobular periphery (39) and pericentral hepatocytes (32) , respectively. Indeed, bile acid-CoA-amino acid N-acyltransferase (BAAT) mRNA, the enzyme involved in the conjugation of taurine and glycine with cholic acid, has been found in higher concentrations in periportal hepatocytes (13) . In contrast, [ 32 S]cysteine is incorporated into taurine much faster in pericentral hepatocytes (32) . This discrepancy between the sites of taurine synthesis and its conjugation could be explained by the supply of taurine from the circulating blood to periportal hepatocytes. In support of this hypothesis, oral administration of taurine increases the percentage of taurine-conjugated bile acids although a glycine diet does not affect the formation of glycine-conjugated bile acids in humans (37) . It is thus conceivable that a taurine transport system in peripotal hepatocytes determines the conjugation pattern of bile acids in hepatocytes. Clarifying the mechanism(s) of taurine uptake by hepatocytes from the blood stream will shed new light on how taurine should be supplemented.
The cellular transport of taurine is mediated by an Na ϩ -and Cl Ϫ -dependent taurine transporter (TauT/SLC6A6) with a high affinity (K m ϭ 43 M) (38) , an Na ϩ -and Cl Ϫ -dependent mouse ␥-aminobutyric acid (GABA) transporter 3 (GAT3/ SLC6A13), the ortholog of rat GAT2 (SLC6A13) with moderate affinity (K m ϭ 540 M) (20) , and proton-coupled amino acid transporter 1 (PAT1/SLC36A1) with a low affinity (K m ϭ 7.5 mM) (1) . Earlier studies have demonstrated that taurine uptake by freshly isolated rat hepatocytes (29) and primary cultures of rat hepatocytes (15, 28) was Na ϩ -and concentration-dependent with a K m value of 37-76.9 M, which is comparable with that of TauT (38) . However, it has become evident that TauT-knockout mice exhibit only a 30% reduction in the taurine content of liver parenchymal cells in spite of severe taurine depletion in nonparenchymal liver cells, such as Kupffer cells and sinusoidal endothelial cells (45) . Furthermore, TauT-knockout did not affect the content of taurineconjugated bile acids in bile (45) . It thus appears that TauT does not play a major role in taurine uptake by hepatocytes. Other studies have revealed that Na ϩ -dependent taurine uptake by rat liver sinusoidal/basolateral plasma membrane vesicles exhibited saturation kinetics with a K m value of 174 -380 M (7, 18), which is close to the that of mouse GAT3 (20) . These lines of evidence prompted us to hypothesize that a GABA transporter on the sinusoidal membrane of periportal hepatocytes makes a substantial contribution to taurine uptake and its subsequent conjugation.
The purpose of the present study was to identify the transporter responsible for taurine uptake by hepatocytes using the in vivo liver uptake index method, freshly isolated hepatocytes, an expression system of Xenopus laevis oocytes, and the gene knockdown method. The sinusoidal membrane localization in periportal hepatocytes of a responsible transporter was determined by immunohistochemical analysis.
MATERIALS AND METHODS
Animals. Adult male Wistar rats (260 -280 g) were purchased from Japan SLC (Hamamatsu, Japan) and maintained in a controlled environment. All experiments were approved by the Animal Care Committee, University of Toyama. Liver uptake index method. The unidirectional uptake of taurine by rat liver was determined by injecting [ 3 H]taurine into the portal vein, as previously reported (30) . Rats were anesthetized by intraperitoneal injection of pentobarbital (50 mg/kg body wt), and their rectal temperatures were maintained at 37°C using a hot plate. The hepatic artery was ligated, and 200 l Ringer's HEPES buffer (pH 7.4) containing both 10 Ci [ 3 H]taurine and 0.5 Ci [ 14 C]butanol as a highly diffusible internal reference, was rapidly injected into the portal vein. Eighteen seconds after injection, the right major lobe was excised from the liver and solubilized in Soluen-350 (Perkin-Elmer Life and Analytical Sciences, Boston, MA). The radioactivity of 3 H and 14 C in the liver and the injection solutions was determined using a liquid scintillation spectrophotometer (model LSC-5000; Aloka, Tokyo, Japan). The liver uptake index (LUI) is defined as LUI ϭ ET/ER, and was determined by LUI (%) The apparent fractional extractions consist of intracellular uptake, distribution to the interstitial space, and retention in the vascular space. Therefore, the extravascular extraction of [ 3 H]taurine, which reflects only the intracellular uptake, was obtained as follows: the extravascular extraction ϭ (ET-Ens)/(100-Ens), where, Ens represents the fractional extraction for distribution in the vascular and extracellular space. In this calculation, we used the reported Ens value of 13 Ϯ 3% for rats (30) .
[ 3 H]Taurine uptake by freshly isolated hepatocytes. Rat hepatocytes were isolated by collagenase perfusion and Percoll isodensity centrifugation as described previously (4) . The hepatocytes were resuspended in Tyrode buffer containing (in mM) 137 NaCl, 2.7 KCl, 1.05 MgCl2, 1.8 CaCl2, 12 NaHCO3, 0.4 NaH2PO4, 5.6 D-glucose. [ 3 H]Taurine uptake by the freshly isolated hepatocytes was examined by methods described previously (33) . In brief, after centrifugation and aspiration of the buffer, uptake was initiated by applying 100 l Tyrode buffer containing [ 3 H]taurine (75 nM) at 37°C in the presence or absence of inhibitors. Na ϩ -free Tyrode buffer was prepared by replacement of NaCl, NaH 2PO4 and NaHCO3 with equimolar Nmethyl-D-glucamine, KH2PO4, and KHCO3, respectively. Cl Ϫ -free uptake buffer was prepared by replacement with equimolar gluconate. After a predetermined period, uptake was terminated by centrifugation of the solution. The cells were then solubilized in 1 N NaOH and subsequently neutralized with 1 N HCl. The cell-associated radioactivity and protein content were assayed by liquid scintillation spectrometry and detergent-compatible protein assay (a DC protein assay kit; Bio-Rad, Hercules, CA) with BSA as a standard.
Kinetic analyses. The kinetic parameters for taurine uptake by freshly isolated rat hepatocytes were obtained from V ϭ (V max ϫ C)/(K m ϩ C) ϩ Kd ϫ C, where V is the uptake rate of taurine, C is the taurine concentration in the medium, K d is the nonsaturable uptake rate, K m is the Michaelis-Menten constant, and V max is the maximum uptake rate. To obtain kinetic parameters, the equation was fitted using the iterative nonlinear least-squares regression analysis program, MULTI (46) .
The median inhibitory concentration (IC50) value of GABA, ␤-alanine, and guanidinoacetic acid (GAA) for are the minimum percentage of control, the maximum percentage of control, and the concentration of inhibitor, respectively.
Immunoblotting. The hepatocytes were homogenized using the nitrogen cavitation technique (800 psi, 15 min, 4°C) in buffer with the following composition (in mM): 10 HEPES, 1 EDTA, 1 EGTA, 320 sucrose, 1 PMSF, and a protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO), pH 7.4. The homogenates were centrifuged at 10,000 g for 15 min, and the supernatants were then further centrifuged at 100,000 g for 60 min to obtain a crude membrane fraction from the pellets. The protein concentration was determined using a DC protein assay kit (Bio-Rad). Protein samples (50 g per lane) were fractionated by SDS-PAGE and electroblotted onto a nitrocellulose membrane. The blotted membrane was incubated with an affinity-purified antibody to GAT2 (Sigma Aldrich), at 1 g/ml in Tris-buffered saline (TBS; 25 mM Tris·HCl, pH 8.0 and 125 mM NaCl, pH 7.4) containing 0.1% Tween 20 and 4% skimmed milk for 16 h at 4°C, and visualized with an enhanced chemiluminescence kit (GE Healthcare).
RNA interference. RNA interference was performed using the BLOCK-iT Pol II miR RNAi expression kit according to the manufacturer's protocol (Invitrogen, Carlsbad, CA). Short hairpin RNAs (shRNAs) unrelated to and targetting GAT2/SLC6A13 (cat. no. Rmi603286; Invitrogen) were expressed in primary cultured rat hepatocytes using Lipofectamine 2000 reagent (Invitrogen) as reported previously (12) . Quantitative real-time PCR was performed using the Mx3000P QPCR system, (Stratagene, La Jolla, CA) with SYBR Premix ExTaq II (Takara, Shiga, Japan) and gene specific primers: forward, 5=-gaagaaccggagggagattc-3= and reverse, 5=-gagaacaggaaggttgccag-3= for rat GAT2 through 40 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 30 s. A standard curve was generated for each run using different amounts of the plasmid containing the target gene. This allowed quantification of the initial copy number of the target mRNA in the samples despite the different PCR conditions of the target genes. Each mRNA expression level was normalized with respect to the ␤-actin mRNA expression as described previously (42) .
[ 3 H]GABA and [ 3 H]taurine uptake by rat GAT2-expressing xenopus laevis oocytes. Using T7 RNA polymerase, capped cRNA was transcribed from NotI-linearized pGEM-HEN containing an open reading frame of rat GAT2 cDNA. Defolliculated oocytes were injected with 23 nl water or the capped cRNA (30 -50 ng) and incubated at 18°C in freshly prepared standard oocyte saline solution containing 100 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES, 25 g/ml gentamycin, 2.5 mM pyruvate, and 1% BSA, pH 7.5. The standard oocyte saline solution used to incubate the oocytes was replaced daily with fresh solution. Experiments were performed after incubation for 4 to 6 days. For the uptake study by Xenopus oocytes, the oocytes were preincubated with 500 l ND96 solution for 20 min at 20°C before the uptake experiment. The uptake experiment was initiated by replacing the ND96 solution with 200 l of the same solution containing [ 3 H]GABA (28 nM) and [ 3 H]taurine (83 nM). After incubation for a designated time at 20°C, the uptake was terminated by addition of ice-cold ND96 solution. Oocytes were then washed four times with ice-cold ND96 solution and solubilized in 5% SDS solution, and the accumulated radioactivity was determined in a liquid scintillation counter (model LSC-5000, Aloka).
Immunohistochemistry. Under deep pentobarbital anesthesia (100 mg/kg body wt ip), the liver of adult rats was removed after transcardial fixation with 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4). The liver was immersed in 30% sucrose in 0.1 M sodium phosphate buffer solution. Frozen sections (40 m in thickness) were prepared on a cryostat (model CM1900; Leica, Nussloch, Germany) and immunohistochemistry was performed as described previously (40) . In brief, sections were immunoreacted overnight with guinea pig antibody to GAT2 (2 g/ml, Sigma Aldrich) singly or in combination with rabbit glutamine synthetase (GS) antibody [1 g/ ml, (25) ] or mouse catalase antibody (5 g/ml, Sigma Aldrich). Subsequently, they were incubated with species-specific Alexa Fluor 488-conjugated secondary antibody (Invitrogen) for 2 h. Photographs were taken using a confocal laser scanning microscope (model TCS-SP5; Leica).
Statistical analysis. All data except for kinetic parameters are presented as the means Ϯ SE. The kinetic parameters are presented as the means Ϯ SD. An unpaired, two-tailed Student's t-test was used to determine the significance of differences between two group means. One-way ANOVA followed by the modified Fisher's least-squares difference method was used to assess the statistical significance of differences among means of more than two groups. 3 H]taurine by 63% and 43%, respectively, each at a concentration of 1 mM, whereas GABA and taurine at the same concentration did not produce any statistically significant inhibition. GABA, taurine, ␤-alanine, and nipecotic acid, each at a concentration of 10 mM, reduced the extravascular extraction of [ 3 H]taurine by Ͼ 70%. L-Alanine had no effect at a concentration of 10 mM. These results suggest that taurine undergoes blood-to-liver influx transport via a carrier-mediated process.
RESULTS

In
[ 3 H]Taurine uptake by freshly isolated rat hepatocytes. The kinetics and characteristics of taurine uptake by freshly isolated rat hepatocytes were investigated. [ 3 H]Taurine uptake by hepatocytes exhibited time-dependent increases (Fig. 1A) . The absence of either Na ϩ or Cl Ϫ reduced the [ 3 H]taurine uptake by 66.4% and 28.4%, respectively (Fig. 1B) . As shown in Fig. 1C (Table 2 ) using several inhibitors, each at a concentration of 10 mM. Substrates for TauT and/or GATs, such as GABA, ␤-alanine, taurine, GAA, and hypotaurine, produced a marked inhibiton of Ͼ 40%.
Inhibitors for TauT and/or GAT, such as ␤-guanidinopropionic acid, ␥-guanidinobutyric acid, and nipecotic acid, also inhibited the uptake by Ͼ 30%. In contrast, creatine, betaine, and L-alanine had no significant effect, indicating that the creatine transporter and betain-GABA transporter 1 (BGT1/SLC6A12) do not play a role. GABA, ␤-alanine, and GAA inhibited the [ 3 H]taurine uptake in a concentration-dependent manner with an IC 50 value of 95.0 Ϯ 49.1 M (Fig. 2A) , 274 Ϯ 112 M . Each column represents the mean Ϯ SE (n ϭ 3). *P Ͻ 0.01, significantly different from control. C: concentration-dependence of taurine uptake by hepatocytes. The uptake was measured for 5 min over the concentration range 50 M to 20 mM. V, uptake rate of taurine; C, taurine concentration in the medium. Each point represents the mean Ϯ SE (n ϭ 3-4). Data were subjected to Eadie-Scatchard analysis.
( Fig. 2B) , and 474 Ϯ 151 M (Fig. 2C) 3 H]taurine uptake study using freshly isolated hepatocytes suggests a contribution by the GABA transporter. Among GABA transporter subtypes in rats (GAT1/ SLC6A1, GAT2/SLC6A13, GAT3/SLC6A11, and BGT1/ SLC6A12), GAT2 exhibits predominant expression in the liver (6) . Fig. 3A confirms the protein expression of GAT2 in the hepatocytes. To examine the functional involvement of rat GAT2 in taurine uptake by hepatocytes, rat GAT2 was silenced by the expression of shRNA to rat GAT2 in a primary culture of rat hepatocytes as previously reported (12) . Quantitative RT-PCR revealed that the GAT2 mRNA expression was decreased by 38% in rat GAT2-silenced hepatocytes compared with those expressing the GAT2 sequence-unrelated shRNA (Fig. 3B) . The [ 3 H]taurine uptake was reduced to a similar extent (28.4%) in rat GAT2-silenced rat hepatocytes (Fig. 3C) . These results suggest that rat GAT2 makes a major contribution to [ 3 H]taurine uptake by hepatocytes. As a positive control, the [ 3 H]GABA uptake by rat GAT2-expressing Xenopus oocytes (GAT2/oocytes) was 105-fold higher than that by water-injected oocytes (Fig. 3D) . [ 3 H]Taurine was taken up by GAT2/oocytes, and the uptake in these oocytes was 63-fold higher than in water-injected oocytes (Fig. 3E) . This result indicates that rat GAT2 accepts taurine as a substrate. Each value represents the mean Ϯ SE (n ϭ 3-9). [ 3 H]taurine (75 nM) uptake by rat hepatocytes was measured at 37°C for 5 min in the absence (control) and presence of inhibitors (10 mM). *P Ͻ 0.01, significantly different from control. GBA, guanidinobutyric acid; GPA, guanidinopropionic acid. ) by Xenopus laevis oocytes injected with water (water; white column) and rat GAT2 cRNA (GAT2; black column) for 1 h. Each column represents the mean Ϯ SE (n ϭ 10 -14). *P Ͻ 0.01, significantly different from control.
Localization of GAT2 in rat liver. The immunostaining of GAT2 showed the heterogeneous distribution pattern in rat liver (Fig. 4A) . The distribution patterns of GAT2 and GS were reciprocal (Fig. 4, B-E) : GS was mainly distributed in hepatocytes around the central vein (Fig. 4, B and D) , whereas GAT2 was mainly labeled in those around the portal spaces (Fig. 4, C and E) . The enlarged image showed that GAT2 was localized on the sinusoidal plasma membrane of the hepatocytes (Fig. 4F) . Because it has been reported that BAAT is localized inside the peroxisomes (31), double immunofluorescence of GAT2 and a peroxisomal marker, catalase, was examined. No overlap was seen between GAT2 and catalase immunoreactivities (Fig. 4G) , suggesting that GAT2 does not contribute to the peroxisomal uptake of taurine.
DISCUSSION
An immunohistochemical study with taurine antiserum has demonstrated that taurine and taurine-conjugated bile acids are abundant in periportal hepatocytes compared with pericentral hepatocytes (10) . In contrast, taurine is synthesized mainly in pericentral hepatocytes (32) . One possible explanation for this discrepancy is that the hepatic supply of taurine from the blood stream is a regulatory factor that determines the contents of taurine and taurine conjugates in periportal hepatocytes. The present finding that GAT2 is responsible for taurine transport from the circulating blood to hepatocytes in the periportal region strongly supports this hypothesis.
The characteristics of [ 3 H]taurine uptake by freshly isolated rat hepatocytes (Figs. 1-3 and Table 2 ) support the belief that GAT2 plays a major role in taurine uptake by hepatocytes, especially based on the following evidence: 1) absence of Na ϩ and Cl Ϫ reduces [ 3 H]taurine uptake by 66.4% and 28.4%, respectively (Fig. 1B); 2) The K m value of [ 3 H]taurine uptake (594 M; Fig. 1C (Fig. 3C) corresponding to the reduction in mRNA expression of GAT2 (Fig. 3B) . The Na ϩ -dependence (66.4%; Fig. 1B) of [ 3 H]taurine uptake by hepatocytes is consistent with the degree of inhibition by GABA and ␤-alanine (ϳ50%; Table 2 ) each at a concentration of 10 mM. Since the IC 50 values of GABA and ␤-alanine for [ 3 H]taurine uptake by hepatocytes is 95.0 M and 274 M (Fig. 2) , respectively, GABA and ␤-alanine, each at a concentration of 10 mM, should exhibit maximum inhibition. Therefore, GAT2 would make at least a 50% contribution to the total (Fig. 1C) . Thus, it appears that GAT2 is mainly responsible for carrier-mediated taurine uptake by hepatocytes.
In vivo hepatic uptake of [ 3 H]taurine after its bolus injection into the portal vein is inhibited by taurine, GABA, ␤-alanine, and nipecotic acid but not by L-alanine, each at a concentration of 10 mM ( Table 1 ). Considering that 1) both TauT and GAT2 accept taurine, GABA and ␤-alanine as substrates but not L-alanine (20, 21, 38, 43) ; and 2) GAT2 is inhibited by nipecotic acid (21) , in vivo hepatic uptake of [ 3 H]taurine seems to be mediated by both TauT and GAT2. However, taurine and GABA did not exhibit a statistically significant inhibition, each at a concentration of 1 mM (Table 1 ). This would be because taurine and GABA, each at a concentration of 1 mM, cannot completely inhibit GAT2-and TauT-mediated [ 3 H]taurine transport, respectively. Indeed, there is a one-to-three order of magnitude difference in the K m values of TauT and GAT2 for taurine and GABA [rat TauT-taurine; 43 M (38), rat TauT-GABA; 2.0 mM (43) , mouse GAT3 (the ortholog of rat GAT2)-taurine; 540 M (20), and rat GAT2-GABA; 8 M] . The discrepancy between the characterization of in vivo and in vitro taurine uptake by the liver needs an explanation. In vivo hepatic uptake of [ 3 H]taurine after its bolus injection into the portal vein reflects not only the uptake by hepatocytes but also by nonparenchymal liver cells, such as Kupffer cells and sinusoidal endothelial cells. TauT-knockout mice exhibit severe taurine depletion in these nonparenchymal liver cells, whereas the content of taurine in hepatocytes is reduced by only 30% (45) . Therefore, TauT would be responsible for taurine uptake by Kupffer cells and sinusoidal endothelial cells. On the other hand, the reference to TauT in Kupffer and endothelial cells may not be sufficient, because it does not explain the discrepancy in the nipecotic acid sensitivity (Tables  1 and 2 ). One possible explanation is that the isolated hepatocytes represent a mixed population of periportal hepatocytes with high levels of GAT2 and pericentral hepatocytes which are essentially lacking GAT2.
Immunohistochemical analysis reveals that GAT2 is localized on the sinusoidal membrane of hepatocytes preferentially in the periportal region (Fig. 4) . This periportal region-predominant distribution is in good agreement with that of BAAT (13), the enzyme for the conjugation of taurine and glycine with cholic acid. BAAT is localized exclusively in peroxisomes (31) , although the presence of BAAT in the cytoplasm remains a matter of debate (17) . The coupling of GAT2 and BAAT suggests that the taurine supply pathway of GAT2 on the sinusoidal membrane of periportal hepatocytes is a key determinant of the conjugation profile with bile acids. However, another form of taurine transport into peroxisomes may need to be considered since GAT2 is not localized in peroxisomes (Fig.  4G) . Previous reports have demonstrated that GAT2 is involved in the hepatic uptake of GABA (19) , ␤-alanine (19), ␥-butyrobetaine, a synthetic precursor of carnitine (12) , and GAA, a biosynthetic precursor of creatine (41) [3.73 M (22) ] are lower than the K m value of GAT2-mediated transport for each compound, GAT2 in hepatocytes would not be fully saturated under physiological conditions. In this regard, the rate of GAT2-mediated taurine uptake seems to depend on the blood concentration of taurine. These observations can explain the fact that, although taurine can be synthesized in hepatocytes (32) , systemic administration of taurine increases the content of taurine-conjugated bile acids (37) as well as taurine itself (24) . This may be especially relevant in the human liver where glycine-conjugated bile salts are present in high concentrations. Since glycine-conjugated bile salts are generally more cytotoxic compared with taurine-conjugated bile salts (36) , oral taurine supplementation used as a therapy could prevent exacerbation of liver damage in cholestatic disease.
Because over 30% of the total bile salt pool is deconjugated by intestinal bacteria on a daily basis (14) , periportal hepatocytes must possess a system for unconjugated bile acid uptake for BAAT-mediated re-conjugation. Several sinusoidal membrane transporters (3, 8) e.g., sodium-dependent taurocholate cotransporting polypeptide (Ntcp/Slc10a1), and organic anion transporting polyeptides (oatp1a1/Slco1a1, oatp1a4/Slco1a4, oatp1b2/Slco1b2), accept unconjugated bile acids as substrates (9, 11, 23, 26) . Their distributions are zonated to the liver as is the case for GAT2: even an acinar distribution for Ntcp and oatp1a1 (3), and pericentral hepatocyte-predominant expression for oatp1a4 (34) and oatp1b2 (8) . Thus, the combination of GAT2, Ntcp, and oatp1a1 would play a key role in the reconjugation of taurine and de novo synthesis of taurineconjugated bile salts in periportal hepatocytes.
In conclusion, GAT2 plays a major role in taurine uptake by periportal hepatocytes on the sinusoidal membrane, thus regulating taurine conjugation with bile acids. The present findings provide a novel insight into the regulatory system of bile salt synthesis and reveal a functional heterogeneity of hepatocytes with respect to transport activity.
